Prostate Cancer Market: How Is Genetic Testing and Precision Oncology Transforming Market Dynamics?
Prostate cancer genetic testing — the germline and somatic molecular profiling enabling treatment selection, hereditary risk assessment, clinical trial eligibility, and prognostic stratification — creates the companion diagnostic commercial market, with the Prostate Cancer Market reflecting precision oncology testing as an increasingly important commercial market dimension. Germline...
0 Kommentare 0 Anteile 29 Ansichten 0 Vorschau